Maturity-Onset Diabetes of the Young (MODY) Diagnosis and Management

Core Definition and Pathophysiology

The American Diabetes Association notes that MODY is a monogenic form of diabetes caused by autosomal dominant genetic mutations affecting insulin secretion, classically presenting before age 25 years with a strong multigenerational family history, and representing less than 5% of all diabetes cases 1
MODY is fundamentally different from type 1 and type 2 diabetes because it results from single-gene mutations inherited in an autosomal dominant pattern, meaning it passes through successive generations with a 50% transmission risk 1
The primary defect involves impaired insulin secretion with minimal or no defects in insulin action, distinguishing it from the insulin resistance seen in type 2 diabetes and the autoimmune destruction in type 1 diabetes 1

Genetic testing should be pursued in children and young adults with diabetes not characteristic of type 1 or type 2 diabetes that occurs in successive generations, as recommended by the American College of Medical Genetics 1
The American Academy of Pediatrics suggests that diabetes diagnosed before age 25 years, strong multigenerational family history, and non-obese patient without metabolic syndrome features are key clinical red flags for MODY 1
The presence of autoantibodies does NOT rule out MODY, as autoantibodies have been reported in patients with monogenic diabetes, according to the American Diabetes Association 2

The American College of Clinical Endocrinologists recommends that the treatment approach differs dramatically based on MODY subtype, making genetic diagnosis clinically essential rather than academic 1
For GCK-MODY (MODY 2), no treatment is required in most cases, and lifestyle modifications only are recommended, as suggested by the European Association for the Study of Diabetes 1
For HNF1A-MODY and HNF4A-MODY (MODY 3 and 1), low-dose sulfonylureas are first-line therapy due to high sensitivity, according to the International Society for Pediatric and Adolescent Diabetes 1

MODY represents less than 5% of all diabetes cases but is frequently misdiagnosed as type 1 or type 2 diabetes, resulting in inappropriate treatment, as noted by the American Diabetes Association 4
GCK-MODY has a very low risk of microvascular complications, while HNF1A-MODY and HNF4A-MODY have similar vascular complication rates to type 1 and type 2 diabetes if inadequately controlled, according to the European Association for the Study of Diabetes 1